Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.70 per share which beat the analyst consensus estimate of $0.65 by 7.36 percent. This is a 11.39 percent decrease over earnings of $0.79 per share from the same period last year. The company reported quarterly sales of $179.516 million which missed the analyst consensus estimate of $182.552 million by 1.66 percent. This is a 6.49 percent increase over sales of $168.573 million the same period last year.